A Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine versus Rectal Indomethacin Alone for the Prevention of Post-ERCP Pancreatitis in High-Risk Patients: 2017 Category Award (Interventional Endoscopy)

Outcomes of per oral endoscopic pyloromyotomy in gastroparesis worldwide

“…Although recall bias could not be completely eliminated, clinical response rate of POP has been very encouraging with significantly improved symptoms and quality of life ranging from 73%-100% at up to 18-mo follow-up period[37,43,45,47,56]. All studies but one showed significant drop in total GCSI after POP[43,48,61,67]. The symptoms that improve the most were nausea and vomiting, while bloating and abdominal distension were not consistently improved among existing studies[37,43,45,47,48,56,58].…”

Analysis of risk factors associated with endoscopic retrograde cholangiopancreatography for patients with liver cirrhosis: a multicenter, retrospective, clinical study

“…Surgery has been considered a contraindication for advanced liver disease because cirrhosis is a significant risk factor for postoperative perioperative complications. [4][5][6] The safety and outcomes of ERCP for patients with cirrhosis are unclear because the literature regarding the safety of ERCP with cirrhosis mainly comprises small retrospective studies or database studies. [7] The objective of this large, multicenter, retrospective study was to determine the efficacy and safety of therapeutic ERCP for patients with cirrhosis.…”

“…They are also at increased risk for adverse events because of underlying liver dysfunction and esophageal varices. Surgery has been considered a contraindication for advanced liver disease because cirrhosis is a significant risk factor for postoperative perioperative complications [4–6] . The safety and outcomes of ERCP for patients with cirrhosis are unclear because the literature regarding the safety of ERCP with cirrhosis mainly comprises small retrospective studies or database studies [7] .…”